BOSTON--(BUSINESS WIRE)--Symmetrical Health, LLC, doing business as Cimilre Breast Pumps, announced today that the Centers for Medicare & Medicaid Services (CMS) has established a new HCPCS Level II ...

Please provide your email address to receive an email when new articles are posted on . If approved, the add-on code would be implemented in 2025. The add-on code could be applied to hospital ...

The Centers for Medicare and Medicaid Services (CMS) issued a second Healthcare Common Procedure Coding System (HCPCS) code to be used by laboratories for the testing and tracking of new cases of the ...

In a move that acknowledges the gauntlet the US health system poses for people facing serious and fatal illnesses, Medicare will pay for a new class of workers to help patients manage treatments for ...

The Centers for Medicare & Medicaid Services recently established a unique Healthcare Common Procedure Coding System (HCPCS) Level II code for the RelieVRx program, AppliedVR’s flagship product. The ...

SAN DIEGO, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) offering CLIA-certified laboratory developed tests (LDTs) based ...

Please provide your email address to receive an email when new articles are posted on . Often, CMS and private insurers have different payment rules and bundling packages. CMS created and owns the ...

CMS recently passed the 90/10 final rule, extending the 2011 regulation on federal funding for Medicaid Eligibility systems. The ruling is just one of the latest efforts by CMS to support states ...

Washington, DC - The Centers for Medicare and Medicaid Services (CMS) has proposed a new rule for fiscal year 2004 that would see, among other changes, an increase in reimbursement for implantation of ...

Symmetrical Health, LLC, doing business as Cimilre Breast Pumps, announced today that the Centers for Medicare & Medicaid Services (CMS) has established a new HCPCS Level II code A4288, “Valve for ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that ...